GET MORE FROM MEDICINES.
RxAnte delivers analytics-powered solutions and clinical services that enable health plans, care providers, and pharmaceutical manufacturers to realize more value from medicines.
-
Our mission is to improve how medicines are prescribed, taken, and paid for. We do things like:
Help health plans improve Medicare Part D and HEDIS quality measures and avoid medical costs related to medication non-adherence.
Enable care providers to better understand and address barriers to their patients’ medication use.
Inform meaningful, evidence-driven discussions with pharmaceutical manufacturers and health plans about drug performance and contracting.
-
The no-obligation RxAnte Adherence Strategy Report is how top-performing Part D plans design their adherence programs.
Highly accurate performance forecasting. Know where you’ll land on the triple-weighted measures this year.
Program simulations. Learn how many interventions are needed to achieve your adherence goals.
Strategic advisory services. Our experts guide your program strategy.
-
Stars Tool: 2019 CMS Stars Data Now Available
Our interactive tool for health plans has been updated. See Star Ratings comparisons across medication measures and the correlation between them. Filters, sliders, and hover capabilities let you see what you need to succeed against rising cut points.
The Results
Below are a few ways we measure medication performance improvement for our clients:
of Medicare Part D contract measures managed by RxAnte improve year-over-year
in annual savings opportunities identified for a health plan deploying our medical cost savings solution.
adherence improvement among plan members reached using our RxEffect® medication adherence workflow solution.
For Health Plans
Deploy our analytics-powered solutions to improve clinical quality, achieve medical cost savings, and better realize the value of medicines on your member populations.
Tell Me More
For Providers
Drive improvements in shared risk arrangements using our predictive analytics and direct-to-patient interventions to ensure patients’ adherence to their medicines.
Tell Me MoreFor Pharmaceutical Manufacturers
Demonstrate the value of drugs on real-world populations and engage in value-based contracts using our evidence-driven approach and transparent performance measurement analytics.
Tell Me More
Resources & Blog
More Resources
Members as Consumers – What it Means for MAPD Plans
Blog Post
The healthcare system once operated without really having to consider what patients or members wanted. We're here to help plans in the shift to patient-centered care.
Controlling CMS Star Ratings – Part III
Blog Post
In this blog series, we have been discussing how MAPD plans can improve their Star Ratings by using analytics to get greater control of their future in an uncertain market. Here we’ll be focusing on the role of analytics in predictive value and care delivery.
Controlling CMS Star Ratings – Part II
Blog Post
In our last blog post, we began to discuss how MAPD plans, amid so much market uncertainty, have the potential to not just control but improve their Star Ratings. Here, we build on that blog to discuss identifying the right members to reach and refining intervention methods to meet those members’ individual needs.
Request More Info
Think RxAnte might be right for your organization? Let’s get in touch.
Let's Get StartedUpcoming Events
More Resources
RISE Nashville (March 17-19, 2019)
Event
RxAnte will be attending RISE Nashville from March 17-19, 2019, located in booth #123. We’ll be available to discuss the latest in medication adherence solutions to help health plans looking to reduce costs and optimize their adherence strategies to achieve their operational and Star Ratings goals.
AMCP Annual Meeting (March 25-28, 2019)
Event
RxAnte is attending the AMCP Annual Meeting March 25-28, 2019. Listen in on a session led by Kerri Petrin, VP of Client Services at 1:30pm March 27, and stop by booth #808 to discuss the latest developments in medication adherence solutions with RxAnte.